238 related articles for article (PubMed ID: 22326055)
1. The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras.
Gus-Brautbar Y; Johnson D; Zhang L; Sun H; Wang P; Zhang S; Zhang L; Chen YH
Mol Cell; 2012 Mar; 45(5):610-8. PubMed ID: 22326055
[TBL] [Abstract][Full Text] [Related]
2. TIPE2 functions as a metastasis suppressor via negatively regulating β-catenin through activating GSK3β in gastric cancer.
Wu J; Zhang H; Xu C; Xu H; Zhou X; Xie Y; Tao M
Int J Oncol; 2016 Jan; 48(1):199-206. PubMed ID: 26530498
[TBL] [Abstract][Full Text] [Related]
3. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM
J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015
[TBL] [Abstract][Full Text] [Related]
4. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
5. RalGDS is required for tumor formation in a model of skin carcinogenesis.
González-García A; Pritchard CA; Paterson HF; Mavria G; Stamp G; Marshall CJ
Cancer Cell; 2005 Mar; 7(3):219-26. PubMed ID: 15766660
[TBL] [Abstract][Full Text] [Related]
6. Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation.
Murphy GA; Graham SM; Morita S; Reks SE; Rogers-Graham K; Vojtek A; Kelley GG; Der CJ
J Biol Chem; 2002 Mar; 277(12):9966-75. PubMed ID: 11788587
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-directed expression of TIPE2 suppresses gastric cancer growth via induction of apoptosis and inhibition of AKT and ERK1/2 signaling.
Zhu Y; Tao M; Wu J; Meng Y; Xu C; Tian Y; Zhou X; Xiang J; Zhang H; Xie Y
Cancer Gene Ther; 2016 Apr; 23(4):98-106. PubMed ID: 26987289
[TBL] [Abstract][Full Text] [Related]
8. The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways.
Hernandez-Muñoz I; Malumbres M; Leonardi P; Pellicer A
Oncogene; 2000 May; 19(23):2745-57. PubMed ID: 10851075
[TBL] [Abstract][Full Text] [Related]
9. TIPE2 inhibits TNF-α-induced hepatocellular carcinoma cell metastasis via Erk1/2 downregulation and NF-κB activation.
Zhang YH; Yan HQ; Wang F; Wang YY; Jiang YN; Wang YN; Gao FG
Int J Oncol; 2015 Jan; 46(1):254-64. PubMed ID: 25339267
[TBL] [Abstract][Full Text] [Related]
10. TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway.
Sun H; Zhuang G; Chai L; Wang Z; Johnson D; Ma Y; Chen YH
J Immunol; 2012 Sep; 189(6):2768-73. PubMed ID: 22904303
[TBL] [Abstract][Full Text] [Related]
11. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation.
White MA; Vale T; Camonis JH; Schaefer E; Wigler MH
J Biol Chem; 1996 Jul; 271(28):16439-42. PubMed ID: 8663585
[TBL] [Abstract][Full Text] [Related]
12. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis.
Yan D; Wang J; Sun H; Zamani A; Zhang H; Chen W; Tang A; Ruan Q; Yang X; Chen YH; Wan X
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31662347
[TBL] [Abstract][Full Text] [Related]
13. TIPE2 suppresses the tumorigenesis, growth and metastasis of breast cancer via inhibition of the AKT and p38 signaling pathways.
Zhang Z; Liu L; Liu C; Cao S; Zhu Y; Mei Q
Oncol Rep; 2016 Dec; 36(6):3311-3316. PubMed ID: 27779698
[TBL] [Abstract][Full Text] [Related]
14. ralGDS family members interact with the effector loop of ras p21.
Kikuchi A; Demo SD; Ye ZH; Chen YW; Williams LT
Mol Cell Biol; 1994 Nov; 14(11):7483-91. PubMed ID: 7935463
[TBL] [Abstract][Full Text] [Related]
15. TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
Zhu L; Zhang X; Fu X; Li Z; Sun Z; Wu J; Wang X; Wang F; Li X; Niu S; Ding M; Yang Z; Yang W; Yin M; Zhang L; Zhang M
J Transl Med; 2018 Jan; 16(1):7. PubMed ID: 29343267
[TBL] [Abstract][Full Text] [Related]
16. JAK/STAT3-dependent activation of the RalGDS/Ral pathway in M1 mouse myeloid leukemia cells.
Senga T; Iwamoto T; Kitamura T; Miyake Y; Hamaguchi M
J Biol Chem; 2001 Aug; 276(35):32678-81. PubMed ID: 11432872
[TBL] [Abstract][Full Text] [Related]
17. Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth.
Goi T; Rusanescu G; Urano T; Feig LA
Mol Cell Biol; 1999 Mar; 19(3):1731-41. PubMed ID: 10022860
[TBL] [Abstract][Full Text] [Related]
18. Activation of RalA is critical for Ras-induced tumorigenesis of human cells.
Lim KH; Baines AT; Fiordalisi JJ; Shipitsin M; Feig LA; Cox AD; Der CJ; Counter CM
Cancer Cell; 2005 Jun; 7(6):533-45. PubMed ID: 15950903
[TBL] [Abstract][Full Text] [Related]
19. Tumor Necrosis Factor (TNF)-α-Induced Protein 8-like-2 (TIPE2) Inhibits Proliferation and Tumorigenesis in Breast Cancer Cells.
Wang K; Ren Y; Liu Y; Zhang J; He JJ
Oncol Res; 2017 Jan; 25(1):55-63. PubMed ID: 28081733
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2.
Ruan Q; Wang P; Wang T; Qi J; Wei M; Wang S; Fan T; Johnson D; Wan X; Shi W; Sun H; Chen YH
Cell Death Dis; 2014 Feb; 5(2):e1095. PubMed ID: 24577093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
